🏅 Top 20 Largest Pharmaceutical Companies

List of largest biomedical companies by revenue - Wikipedia
 · List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
30 Biggest Biotechnology Companies in the World - Yahoo Finance
 · The U.S. biotechnology market size was USD 246.18 billion in 2023 and is projected to reach around USD 763.82 billion by 2033 with a CAGR of 11.90%. North America dominated the global ...
30
Mar 17, 2024
Top 31 Biopharma Companies in 2024 - ICH GCP
 · Takeda Pharmaceutical Company Limited - Stock price: 4502 (TYO), is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue ...
31
6 days ago
20 Largest Companies in the World by Market Cap in 2024 - Yahoo Finance
 · Alphabet Inc. 148.74. -0.94. -0.63%. In this article, we will be taking a look at the 20 largest companies in the world by market cap in 2024. If you want to skip our detailed analysis, you can go ...
20
3 days ago
Pharma Industry - Latest News, Investigations and Analysis
 · AstraZeneca is buying Fusion Pharmaceuticals for up to $2.4 billion as part of a plan to accelerate the development of next-generation cancer treatments. By. Ian Walker. March 19, 2024. 1 min read.
5 days ago
Fierce Pharma Biopharma News & Insights
 · Nov 13, 2023 05:00am. See more articles. Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and ...
4 days ago
Biotech M&A is on the upswing. Track the latest deals here.
 · The end of the last decade brought record highs in pharmaceutical M&A as larger companies turned again and again to young biotechs for innovation. Often, these deals focused on cancer, rare diseases and immune system disorders — areas of drug research that were seeing major victories in clinical trials and huge profits for treatments that made it to market.
5 days ago
Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap
 · US$159.73. PS 4.7x. E 70.2%. n/a. Page 1 of 36. Discover U.S. Large Cap Pharmaceuticals & Biotech Stocks that are on the NYSE and NASDAQ.
5 days ago

Top Pharma Companies By Size

List of largest biomedical companies by revenue - Wikipedia
 · The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$10 billion, ranked by their revenue in the respective financial year.. It does not include biotechnology companies that are now owned by, or form a part of, larger pharmaceutical groups.
30 Biggest Biotechnology Companies in the World - Yahoo Finance
 · The U.S. biotechnology market size was USD 246.18 billion in 2023 and is projected to reach around USD 763.82 billion by 2033 with a CAGR of 11.90%. North America dominated the global ...
30
Mar 17, 2024
Top 31 Biopharma Companies in 2024 - ICH GCP
 · Hengrui Pharma ranked 13th in the "Top 25 global pharma companies by pipeline size " selected by Informa Pharma Intelligence in 2023. Samsung Biologics - Stock price: 207940 (KRX); is a South Korean biotechnology company headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, it provides contract development and ...
31
6 days ago
Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap
 · These Pharmaceuticals & Biotech Companies are organised by Market Cap. 🇺🇸 US Market Pharmaceuticals & Biotech. Advanced Filters. Market Cap High to Low. 842 companies. Company Last Price 7D Return 1Y Return Market Cap Analysts Target Valuation Growth Div Yield; LLY. Eli Lilly: US$770.61: 2.2%: 129.3%: US$693.4b: US$797.44: PE 132.4x: E 27 ...
5 days ago
Size and composition of the pharmaceutical market
 · Here are some key details on the size and composition of the pharmaceutical market: Size: The global pharmaceutical market was valued at over $1.3 trillion in 2020, and is projected to reach over $1.5 trillion by 2025. The United States is the largest pharmaceutical market, accounting for around 45% of the global market share.
5 days ago
49 Best UK Pharma Startups to Watch in 2024 - Seedtable
 · Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases. 56. $56M · Series B. Balderton Capital, Atomico, btov Partners. 51 to 100. Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence. B2B, SaaS.
49
6 days ago
About pharmaphorum
 · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep Dive. www.pharmaphorum.com ...
1 day ago
PHARM22E Quote - Bloomberg Europe & US Top Pharmaceuticals 2022 ...
 · Bloomberg Europe & US Top Pharmaceuticals 2022 Decrement 5% Return Index is an equal weighted equity benchmark consisting in a fixed basket of five European and five US pharmaceuticals companies ...
3 days ago

Top 20 Global Pharma Companies

List of largest biomedical companies by revenue - Wikipedia
 · The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$10 billion, ranked by their revenue in the respective financial year.. It does not include biotechnology companies that are now owned by, or form a part of, larger pharmaceutical groups.
Top 31 Biopharma Companies in 2024 - ICH GCP
 · It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue Wikipedia. Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
31
6 days ago
30 Biggest Biotechnology Companies in the World - Yahoo Finance
 · Market Cap: $6.20 billion . Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), a top biotechnology company in Carlsbad, California, specializes in RNA-targeted therapeutics, providing groundbreaking ...
30
Mar 17, 2024
Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap
 · US$159.73. PS 4.7x. E 70.2%. n/a. Page 1 of 36. Discover U.S. Large Cap Pharmaceuticals & Biotech Stocks that are on the NYSE and NASDAQ.
5 days ago
Six takeaways from JP Morgan 2024 | pharmaphorum
 · Discover the top six key takeaways from JP Morgan's 2024 conference, focusing on dealmaking trends in big tech, life science, AI, and advancements in cell and gene therapies, as well as the future ...
5 days ago
Biotech | BioPharma Dive
 · IFM, an unorthodox biotech startup, scores third buyout with Novartis deal. With a decision by the Swiss pharma to acquire another one of its subsidiaries, IFM Therapeutics has now sold three spin-offs for a total of $700 million upfront and the potential for billions more in future payments. By Kristin Jensen • March 13, 2024.
3 days ago
Fierce Pharma Biopharma News & Insights
 · Nov 13, 2023 05:00am. See more articles. Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and ...
4 days ago
Pharma Industry - Latest News, Investigations and Analysis
 · AstraZeneca is buying Fusion Pharmaceuticals for up to $2.4 billion as part of a plan to accelerate the development of next-generation cancer treatments. By. Ian Walker. March 19, 2024. 1 min read.
5 days ago

Highest Market Cap Pharmaceutical Companies

List of largest biomedical companies by revenue - Wikipedia
 · List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap
 · US$159.73. PS 4.7x. E 70.2%. n/a. Page 1 of 36. Discover U.S. Large Cap Pharmaceuticals & Biotech Stocks that are on the NYSE and NASDAQ.
5 days ago
20 Largest Companies in the World by Market Cap in 2024 - Yahoo Finance
 · Tesla Inc. (NASDAQ:TSLA) is an American multinational automotive and clean energy company that ranks among the top 15 on our list of the largest companies in the world by market cap in 2024.
20
3 days ago
10 Top Biotech Companies in the World by Market Cap - Business 2 Community
 · 10. Pfizer – $158.25 Billion. To finish off our list of the best biotech companies in the world, we have Pfizer with a market cap valuation of $158.25 billion. The American international ...
10
5 days ago
Top 31 Biopharma Companies in 2024 - ICH GCP
 · Despite continuous declining trend in market capitalization of the top biotechnology companies, the 25 largest market players achieved the overage capitalization of $1.711 trillion in 2023 (GEN’s Top 25 Biotech Companies of 2023). The top players on the market remain a profitable investment in the long term. Below we provide an overview of the biggest biopharma players in 2024 on the market.
31
6 days ago
Best Pharmaceutical Stocks to Invest In 2024 - Techopedia
 · Best Pharmaceutical Stocks to Buy in 2024. Eli Lilly: Surging sales of diabetes/weight loss drug Mounjaro to treat diabetes and Zepbound to treat obesity, helped Eli Lilly become the world’s most valuable pharmaceutical company. Merck: Its ancer therapy, Keytruda, was the world’s top-selling drug in 2023.
4 days ago
U.S. Pharma Industry Analysis - Simply Wall St
 · Mon, 05 Apr 2021. Current Industry PE. Investors are optimistic on the American Pharmaceuticals industry, and appear confident in long term growth rates. The industry is trading at a PE ratio of 82.7x which is higher than its 3-year average PE of 40.9x. The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 5.2x.
6 days ago
Teva Pharmaceutical (TEVA) Market Cap & Net Worth - Stock Analysis
 · Since December 1, 1998, Teva Pharmaceutical's market cap has increased from $6.10B to $15.61B, an increase of 155.82%. That is a compound annual growth rate of 3.78%. Market Cap History
2 days ago
Related
The Latest Researched:
Popular Research: